BACKGROUND/AIMS: Acute phase C-reactive protein (CRP), elevated in obesity and inflammation, is a major binding protein for leptin. It is thought that CRP contributes to leptin resistance by preventing leptin from crossing the blood-brain barrier (BBB). Here we determined how CRP interacts with the BBB and whether it deters leptin from reaching CNS targets. METHODS: BBB permeability, compartmental distribution, tracer stability, and expression of tight junction protein and inflammatory marker were determined. RESULTS: CRP was stable in blood, but did not permeate the BBB in trace amounts. However, it increased paracellular permeability at a higher dose. Agouti viable (A(vy)) mice with adult-onset obesity show higher CRP entry into the brain. CRP did not permeate hCMEC/D3 cells nor change zona occludin-1 or cyclooxygenase-2 expression. An intermediate dose of CRP had no effect on leptin transport across the BBB after co-treatment. Thus, acute interactions between CRP and leptin at the BBB level were negligible and did not explain the leptin resistance seen in obesity. CONCLUSIONS: The interactions of CRP and the BBB are a two-phase process, with increased paracellular permeability at a high dose that enables its entry into the CNS and serves to induce reactive gliosis and impair CNS function.
BACKGROUND/AIMS: Acute phase C-reactive protein (CRP), elevated in obesity and inflammation, is a major binding protein for leptin. It is thought that CRP contributes to leptin resistance by preventing leptin from crossing the blood-brain barrier (BBB). Here we determined how CRP interacts with the BBB and whether it deters leptin from reaching CNS targets. METHODS: BBB permeability, compartmental distribution, tracer stability, and expression of tight junction protein and inflammatory marker were determined. RESULTS:CRP was stable in blood, but did not permeate the BBB in trace amounts. However, it increased paracellular permeability at a higher dose. Agouti viable (A(vy)) mice with adult-onset obesity show higher CRP entry into the brain. CRP did not permeate hCMEC/D3 cells nor change zona occludin-1 or cyclooxygenase-2 expression. An intermediate dose of CRP had no effect on leptin transport across the BBB after co-treatment. Thus, acute interactions between CRP and leptin at the BBB level were negligible and did not explain the leptin resistance seen in obesity. CONCLUSIONS: The interactions of CRP and the BBB are a two-phase process, with increased paracellular permeability at a high dose that enables its entry into the CNS and serves to induce reactive gliosis and impair CNS function.
Authors: Angela L Jefferson; Joseph M Massaro; Alexa S Beiser; Sudha Seshadri; Martin G Larson; Philip A Wolf; Rhoda Au; Emelia J Benjamin Journal: Neuroepidemiology Date: 2011-07-13 Impact factor: 3.282
Authors: E J van Dijk; N D Prins; S E Vermeer; H A Vrooman; A Hofman; P J Koudstaal; M M B Breteler Journal: Circulation Date: 2005-08-01 Impact factor: 29.690
Authors: Yan Zhang; Xiaojun Wu; Yi He; Abba J Kastin; Hung Hsuchou; Charles I Rosenblum; Weihong Pan Journal: J Neurochem Date: 2009-05-05 Impact factor: 5.372
Authors: Fabian Corlier; George Hafzalla; Joshua Faskowitz; Lewis H Kuller; James T Becker; Oscar L Lopez; Paul M Thompson; Meredith N Braskie Journal: Neuroimage Date: 2018-01-28 Impact factor: 6.556
Authors: Anna L Marsland; Dora C-H Kuan; Lei K Sheu; Katarina Krajina; Thomas E Kraynak; Stephen B Manuck; Peter J Gianaros Journal: Brain Behav Immun Date: 2017-01-23 Impact factor: 7.217
Authors: Christian Lunetta; Andrea Lizio; Eleonora Maestri; Valeria Ada Sansone; Gabriele Mora; Robert G Miller; Stanley H Appel; Adriano Chiò Journal: JAMA Neurol Date: 2017-06-01 Impact factor: 18.302
Authors: Neelesh K Nadkarni; Robert M Boudreau; Stephanie A Studenski; Oscar L Lopez; Ge Liu; Stephen Kritchevsky; Kristine Yaffe; Anne B Newman; Caterina Rosano Journal: Neurology Date: 2016-10-12 Impact factor: 9.910
Authors: Romuald Girard; Yan Li; Agnieszka Stadnik; Robert Shenkar; Nicholas Hobson; Sharbel Romanos; Abhinav Srinath; Thomas Moore; Rhonda Lightle; Abdallah Shkoukani; Amy Akers; Timothy Carroll; Gregory A Christoforidis; James I Koenig; Cornelia Lee; Kristina Piedad; Steven M Greenberg; Helen Kim; Kelly D Flemming; Yuan Ji; Issam A Awad Journal: Neurosurgery Date: 2021-02-16 Impact factor: 4.654
Authors: Carolina Muniz Carvalho; Frank R Wendt; Adam X Maihofer; Dan J Stein; Murray B Stein; Jennifer A Sumner; Sian M J Hemmings; Caroline M Nievergelt; Karestan C Koenen; Joel Gelernter; Sintia I Belangero; Renato Polimanti Journal: Neuropsychopharmacology Date: 2020-03-16 Impact factor: 7.853